Inventor · Laguna Niguel, CA, US

Mark A. Varney

15Patents
4h-index
51Co-inventors
63Inventor score

Filing activity: Aug 31, 1999 → Jan 27, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US8053603B2 Tetralone-based monoamine reuptake inhibitors Chemistry; Metallurgy 24 Active
US6656957B1 Pyridine derivatives Chemistry; Metallurgy 21 Expired
US6956049B1 Methods of modulating processes mediated by excitatory amino acid receptors Human Necessities 6 Expired
US7884124B2 Fluoro-substituted inhibitors of D-amino acid oxidase Chemistry; Metallurgy 5 Active
US8669291B2 Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors Chemistry; Metallurgy 1 Active
US8329950B2 Process for preparation of trans 4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-1Napthalenamine Chemistry; Metallurgy 1 Active
US11090298B2 Method for treating movement disorders with befiradol Human Necessities 0 Active
US8877975B2 Cycloalkylamines as monoamine reuptake inhibitors Chemistry; Metallurgy 0 Active
US10548885B2 Method for treating movement disorders with befiradol Human Necessities 0 Active
US10562853B2 Compounds for treating disorders sensitive to serotoninergic regulation controlled by the 5-HT1A receptors Chemistry; Metallurgy 0 Active
US9586888B2 Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors Chemistry; Metallurgy 0 Active
US11974992B2 Use of serotonin 5-HT1A receptor agonists to treat diseases associated with sudden unexpected death in epilepsy Human Necessities 0 Active
US10562878B2 Cycloalkylamines as monoamine reuptake inhibitors Chemistry; Metallurgy 0 Active
US9868718B2 Cycloalkylamines as monoamine reuptake inhibitors Chemistry; Metallurgy 0 Active
US11191758B2 Use of selective serotonin 5-HT1A receptor agonists for treating side-effects of VMAT inhibitors Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.